Ann ICRP. 2003;33(4):1-117. doi: 10.1016/s0146-6453(03)00024-1.
The effect of ionising radiation is influenced by the dose, the dose rate, and the quality of the radiation. Before 1990, dose-equivalent quantities were defined in terms of a quality factor, Q(L), that was applied to the absorbed dose at a point in order to take into account the differences in the effects of different types of radiation. In its 1990 recommendations, the ICRP introduced a modified concept. For radiological protection purposes, the absorbed dose is averaged over an organ or tissue, T, and this absorbed dose average is weighted for the radiation quality in terms of the radiation weighting factor, w(R), for the type and energy of radiation incident on the body. The resulting weighted dose is designated as the organ- or tissue-equivalent dose, H(T). The sum of the organ-equivalent doses weighted by the ICRP organ-weighting factors, w(T), is termed the effective dose, E. Measurements can be performed in terms of the operational quantities, ambient dose equivalent, and personal dose equivalent. These quantities continue to be defined in terms of the absorbed dose at the reference point weighted by Q(L). The values for w(R) and Q(L) in the 1990 recommendations were based on a review of the biological and other information available, but the underlying relative biological effectiveness (RBE) values and the choice of w(R) values were not elaborated in detail. Since 1990, there have been substantial developments in biological and dosimetric knowledge that justify a re-appraisal of w(R) values and how they may be derived. This re-appraisal is the principal objective of the present report. The report discusses in some detail the values of RBE with regard to stochastic effects, which are central to the selection of w(R) and Q(L). Those factors and the dose-equivalent quantities are restricted to the dose range of interest to radiation protection, i.e. to the general magnitude of the dose limits. In special circumstances where one deals with higher doses that can cause deterministic effects, the relevant RBE values are applied to obtain a weighted dose. The question of RBE values for deterministic effects and how they should be used is also treated in the report, but it is an issue that will demand further investigations. This report is one of a set of documents being developed by ICRP Committees in order to advise the ICRP on the formulation of its next Recommendations for Radiological Protection. Thus, while the report suggests some future modifications, the w(R) values given in the 1990 recommendations are still valid at this time. The report provides a scientific background and suggests how the ICRP might proceed with the derivation of w(R) values ahead of its forthcoming recommendations.
电离辐射的效应受剂量、剂量率和辐射品质的影响。1990年以前,剂量当量的量是根据品质因数Q(L)来定义的,该品质因数应用于某一点的吸收剂量,以考虑不同类型辐射效应的差异。国际放射防护委员会(ICRP)在其1990年的建议中引入了一个修改后的概念。出于放射防护目的,吸收剂量在一个器官或组织T上进行平均,并且这个吸收剂量平均值根据照射到身体上的辐射类型和能量,按照辐射权重因数w(R)对辐射品质进行加权。得到的加权剂量被指定为器官或组织当量剂量H(T)。由ICRP器官权重因数w(T)加权的器官当量剂量之和被称为有效剂量E。测量可以根据操作量、周围剂量当量和个人剂量当量来进行。这些量仍然根据在参考点由Q(L)加权的吸收剂量来定义。1990年建议中的w(R)和Q(L)值是基于对现有生物学和其他信息的审查,但潜在的相对生物效应(RBE)值以及w(R)值的选择并未详细阐述。自1990年以来,生物学和剂量学知识有了重大进展,这证明有必要重新评估w(R)值及其推导方式。这种重新评估是本报告的主要目标。该报告详细讨论了与随机效应相关的RBE值,这些值对于w(R)和Q(L)的选择至关重要。这些因素和剂量当量的量仅限于辐射防护感兴趣的剂量范围,即剂量限值的大致量级。在处理可能导致确定性效应的较高剂量的特殊情况下,应用相关的RBE值来获得加权剂量。报告中也讨论了确定性效应的RBE值问题以及应如何使用这些值,但这是一个需要进一步研究的问题。本报告是ICRP各委员会正在编写的一系列文件之一,目的是就其下一次放射防护建议的制定向ICRP提供咨询。因此,虽然该报告提出了一些未来的修改建议,但1990年建议中给出的w(R)值目前仍然有效。该报告提供了科学背景,并建议ICRP在即将发布的建议之前如何着手推导w(R)值。